for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Idorsia Says Janssen Reports Positive Top-Line Phase 3 Results For Ponesimod

July 26 (Reuters) - IDORSIA LTD:

* JANSSEN REPORTS POSITIVE TOP-LINE PHASE 3 RESULTS FOR PONESIMOD IN ADULTS WITH RELAPSING MULTIPLE SCLEROSIS

* JANSSEN REPORTS POSITIVE TOP-LINE PHASE 3 RESULTS FOR PONESIMOD IN ADULTS WITH RELAPSING MULTIPLE SCLEROSIS

* IDORSIA PHARMACEUTICALS LTD IS ENTITLED TO RECEIVE QUARTERLY PAYMENTS OF 8% OF NET SALES OF PONESIMOD PRODUCTS FROM ACTELION PHARMACEUTICALS LTD

* STUDY MET ITS PRIMARY AND MOST SECONDARY ENDPOINTS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up